Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior ...

Investing.com -- Onemednet Corp (NASDAQ:ONMD) stock surged 41.8% while Palantir Technologies Inc (NYSE:PLTR) shares rose 2.9% in premarket trading Monday after announcing a multi-year partnership to ...

CytomX pivots to CX-2051 in colorectal cancer with early efficacy, GI toxicity concerns, and strong cash runway into 2027.

OneMedNet Corporation (ONMD) has selected Palantir Technologies (PLTR) to transform the healthcare AI and Real-World Data analytics marketplace. Palantir’s Artificial Intelligence Platform will ...

OneMedNet (ONMD) has selected Palantir Technologies (PLTR) to transform the healthcare AI and Real-World Data analytics marketplace. Palantir’s ...

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical ...

The FDA has accepted for priority review the biologics license application (BLA) of Orca-T, an investigational allogeneic ...

Community Health Network today announced the appointment of Patrick McGill, MD, as its new president and chief executive ...

Trajan’s Disruptive Technologies segment is spearheading the global move toward decentralised science with the strategy ...

Recent analyst commentary has emphasized Viking Therapeutics' advanced clinical programs in the obesity and metabolic disease space, spotlighting the company as an independent player in a ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...